Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase I trial is studying the side effects and best dose of gemcitabine when given
together with radiation therapy and cisplatin in treating patients with cervical cancer that
has not spread beyond the pelvis. Radiation therapy uses high-energy x-rays to damage tumor
cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining cisplatin with gemcitabine may make the tumor cells more
sensitive to radiation therapy and may kill more tumor cells.